MOL CARCINOGEN 润色咨询

MOLECULAR CARCINOGENESIS

出版年份：1988 年文章数：1469 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2024-05-15 ms7000000138744330 来自江苏省

    偏重的研究方向：肿瘤
    经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2023-02-18 ms9000001393570186 来自重庆

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）
    2023-2-18催稿无反应
    -后续更新

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2024-05-13 ms8000001259738614 来自黑龙江省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：磨磨蹭蹭

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2024-04-08 ms5000001127810224 来自浙江省

    审稿速度:6.0
    偏重的研究方向：肿瘤
    经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2024-03-28 ms1000001248507298 来自江苏

    偏重的研究方向：肿瘤;非编码RNA;分子机制
    经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2024-04-18 lijiwei.li_99476115 来自河南省

    大神们，这个杂志需要原始数据吗

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2023-04-06 ms7000001027936853 来自重庆

    偏重的研究方向：肿瘤;非编码RNA
    经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2023-03-28 ms7000000699329508 来自广东省

    想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2023-03-06 ms7000000359211492 来自浙江省

    二审三个月 催稿不回 醉了

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤<br>经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）<br>2023-2-18催稿无反应<br>-后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：磨磨蹭蹭<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆)]
    2023-01-28 ms7000001027936853 来自重庆

    偏重的研究方向：肿瘤;分子机制
    经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复

    11

    展开11条回复
共158条页码: 1/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分